Trial NCT02774291

View at ClinicalTrials.gov 
Org. Study IDs: 2015-5254
Secondary IDs: 2015-5254 NCI-2015-01781 P30CA013330

Last trial update was posted on 2023-08-04

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine Fludarabine phosphate Interleukin-2 Lenograstim

MeSH Conditions

Neoplasms Neoplasms, Second Primary

Other Conditions

HLA-A2 Positive Cells Present Metastatic Malignant Neoplasm Metastatic Malignant Neoplasm in the Brain

Stopping Reasons

Due to lack of accrual the study was formally terminated on 01-JUL-2020. Primary Completion and Study Completion Dates have been revised based accordingly based on respective definitions

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID